Cargando…

Brain-derived neurotrophic factor in main neurodegenerative diseases

Detalles Bibliográficos
Autores principales:	Camuso, Serena, Canterini, Sonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727459/ https://www.ncbi.nlm.nih.gov/pubmed/36018175 http://dx.doi.org/10.4103/1673-5374.350199

Ejemplares similares

The Antifungal Antibiotic Filipin as a Diagnostic Tool of Cholesterol Alterations in Lysosomal Storage Diseases and Neurodegenerative Disorders
por: Bruno, Francesco, et al.
Publicado: (2023)

Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases
por: Azman, Khairunnuur Fairuz, et al.
Publicado: (2022)

Glial cell line-derived neurotrophic factor in brain repair after focal ischemic stroke
por: Zhang, Zhe, et al.
Publicado: (2022)

When and how does brain-derived neurotrophic factor activate Nrf2 in astrocytes and neurons?
por: Ishii, Tetsuro, et al.
Publicado: (2018)

The potential of small molecule brain-derived neurotrophic factor: mimetics to treat inherited retinal degeneration
por: Cerquone Perpetuini, Andrea, et al.
Publicado: (2019)

The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke
por: Eyileten, Ceren, et al.
Publicado: (2020)

The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: new pharmacological concepts for old and new drugs
por: Habtemariam, Solomon
Publicado: (2018)

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
por: Vance, Jean E.
Publicado: (2012)

Glial cell line-derived neurotrophic factor as a treatment after spinal cord injury
por: Ortmann, Stephen D., et al.
Publicado: (2018)

Reduced Cerebellar BDNF Availability Affects Postnatal Differentiation and Maturation of Granule Cells in a Mouse Model of Cholesterol Dyshomeostasis
por: Lucarelli, Micaela, et al.
Publicado: (2023)

Neurotrophic factors: promising candidates in tissue regeneration
por: Xiao, Nan
Publicado: (2016)

Vascular endothelial growth factor: an essential neurotrophic factor for motoneurons?
por: Calvo, Paula M., et al.
Publicado: (2018)

Dopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells
por: Nekrasov, Pavel V., et al.
Publicado: (2018)

Paracrine factors for neurodegenerative disorders: special emphasis on Parkinson's disease
por: Di Santo, Stefano, et al.
Publicado: (2016)

Is neurotrophic factor a second language that neuron and tooth speak?
por: Xiao, Nan
Publicado: (2021)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Ependyma in Neurodegenerative Diseases, Radiation-Induced Brain Injury and as a Therapeutic Target for Neurotrophic Factors
por: Ma, Xin-Yu, et al.
Publicado: (2023)

Glial derived neurotrophic factor: a sufficient essential molecular regulator of mammalian blood-nerve barrier tight junction formation
por: Dong, Chaoling, et al.
Publicado: (2020)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Brain-derived Neurotrophic Factor in Megakaryocytes
por: Chacón-Fernández, Pedro, et al.
Publicado: (2016)

Brain-derived neurotrophic factor and schizophrenia
por: Gören, Jessica L.
Publicado: (2016)

Brain-derived neurotrophic factor as biomarker
por: Sookaromdee, Pathum, et al.
Publicado: (2020)

Brain-Derived Neurotrophic Factor and Diabetes
por: Rozanska, Olga, et al.
Publicado: (2020)

Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
por: Zuccato, Chiara, et al.
Publicado: (2011)

Patient-Derived iPSCs and iNs—Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases
por: Tang, Bor Luen
Publicado: (2018)

Mammalian target of rapamycin complex 1 as an inducer of neurotrophic factors in dopaminergic neurons
por: Kim, Sang Ryong
Publicado: (2014)

The therapeutic potential of nerve growth factor combined with blood-brain barrier modulation by focused ultrasound for neurodegenerative disorders
por: Xhima, Kristiana, et al.
Publicado: (2021)

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF): An Emerging Therapeutic Target for Neurodegenerative Disorders
por: Sivakumar, Bhadrapriya, et al.
Publicado: (2023)

Inhibition of microglial activation and induction of neurotrophic factors by flavonoids: a potential therapeutic strategy against Parkinson's disease
por: Kim, Sang Ryong
Publicado: (2015)

Synergy of human platelet lysate and laminin to enhance the neurotrophic effect of human adipose-derived stem cells
por: di Summa, Pietro G, et al.
Publicado: (2022)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ui31joq7v380cgiqgt8h2b5sfj